NCT06523543 Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
| NCT ID | NCT06523543 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Montpellier |
| Condition | Pregnant Women |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-11-19 |
| Primary Completion | 2027-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2024-11-19 with a primary completion date of 2027-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.
Eligibility Criteria
Inclusion Criteria: * Pregnant woman * Singleton pregnancy * Pregnancy between 7 and 16 weeks of amenorrhea (WA) * Woman ≥ 18 years * Woman who has signed an informed consent * Woman affiliated to social security or equivalent scheme Exclusions Criteria: * Person under guardianship or curatorship * Person placed under legal protection * Person unable to provide the participant with informed consent.
Contact & Investigator
Vincent GATINOIS, MD
PRINCIPAL INVESTIGATOR
University Hospital, Montpellier
Frequently Asked Questions
Who can join the NCT06523543 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pregnant Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06523543 currently recruiting?
Yes, NCT06523543 is actively recruiting participants. Contact the research team at v-gatinois@chu-montpellier.fr for enrollment information.
Where is the NCT06523543 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT06523543 clinical trial?
NCT06523543 is sponsored by University Hospital, Montpellier. The principal investigator is Vincent GATINOIS, MD at University Hospital, Montpellier. The trial plans to enroll 25 participants.